Charcoal experiment to reverse blood thinners halted before it began

NCT ID NCT02969746

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study was designed to see if taking activated charcoal could help clear certain blood thinners (rivaroxaban, apixaban) faster in patients needing an urgent procedure. It planned to enroll 140 adults and measure how quickly the drug left their blood. However, the trial was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Activated charcoal

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTICOAGULANTS; CIRCULATING, HEMORRHAGIC DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Le MANS

    Le Mans, 72000, France

  • CHU Clermont-ferrand

    Cléron, 63000, France

  • CHU de Poitiers

    Poitiers, 86000, France

  • CHU de St Etienne

    Saint-Etienne, 42000, France

  • Chu Angers

    Angers, 49000, France

  • Chu Angers

    Angers, 49933, France